

About Yinrui Biomedical
Pioneering portable molecular diagnostics since 2018
Ningbo Inarray Biomedical Systems Co., Ltd was founded in June 2018. As a high-precision instrument manufacturer, the company's core technical team is composed of experts and scholars from the Chinese Academy of Sciences, dedicated to the R&D and manufacturing of advanced molecular detection technologies and equipment in life sciences and precision medicine.
The company specializes in digital PCR and fully automated closed nucleic acid qPCR analysis systems, along with related reagents and consumables. We focus on providing efficient nucleic acid detection solutions for professional scientific research and application fields.
The company currently has 69 employees, including 6 PhDs and 12 Masters among its technical and R&D management personnel.
Company at a Glance
Founder

Dr. Yu Jun — Chairman
Biomedical PhD · Professor, University of Chinese Academy of Sciences
Specialty: Genomic Science, Informatics, Scientific Instrument Manufacturing
Career
- NYU School of Medicine, Biomedical PhD (1984–1990)
- Co-founder of BGI (Beijing Genomics Institute) (1999–2008)
- Distinguished Researcher & Founding Vice Director, Beijing Institute of Genomics, CAS (2003–2013)
- Chairman, Ningbo Inarray Biomedical Systems Co., Ltd (2018–present)
- Director, Cixi Life Science Innovation Research Institute (2021–present)
Honors & Awards
- CAS Hundred Talents Program (2002)
- Scientific American — Inaugural Global Science Leader of the Year (2002)
- Qiushi Outstanding Science & Technology Achievement Award (2002)
- CAS Outstanding Science & Technology Achievement Award (2003)
- TWAS Prize for Agricultural Sciences (2012)
- Chief Scientist, National 973 Program (2006–2016)
Certifications & Qualifications
Our manufacturing facility holds ISO 13485 quality management system certification.

Specialized & Innovative SME
Intellectual Property
25 invention patents, 3 utility-model patents and 1 design patent granted, plus software copyrights, covering the analyzer, the microfluidic chip and test applications. ISO 13485 quality system. National High-Tech Enterprise (2024); Ningbo Specialized & Innovative SME (2025); undertook the National Key R&D Program "S&T Winter Olympics" handheld qPCR project and the MOST "Technology-Driven Economic Growth 2020" special project.

R&D & Manufacturing Facility
Our facility at Cixi Industrial Application Technology Research Institute features nearly 3,000m² of laboratory space, GMP workshops, and comprehensive production equipment.






Management Team

Dr. Yu Jun
Chairman & Founder
NYU Biomedical PhD · BGI Co-founder

Zhang Lei
CEO
MMD from Denmark · Secretary-General of Nordic Chinese Association

Sui Shuo
VP — R&D
PhD, Beijing Institute of Genomics, CAS · Postdoc, Institute of Semiconductors, CAS

Liu Yibo
Production Director
MSc Cell Biology, China Medical University

Zhu Dawei
VP — Operations
Former VP, Shandong Greenlight Cable Group · Dell & GDB veteran

Guo Haiyan
R&D Director — Reagents
PhD, Beijing Institute of Genomics, CAS · Former Assoc. Professor
Company Milestones
Yinrui Biomedical founded in Cixi, Zhejiang
Digital PCR project selected for Ningbo 'S&T Innovation 2025' biomedical program
Undertook National Key R&D Program 'S&T Winter Olympics' — handheld qPCR project
COVID-19 border control emergency technology research; selected for MOST 'S&T Boosting Economy 2020'
Digital PCR project selected for Ningbo "3315 Plan" entrepreneurial team
CarryOn P1000Q handheld qPCR system and SARS-CoV-2 chip passed General Administration of Customs project acceptance
Co-founded Cixi Life Science Innovation Research Institute with Cixi government
Named "Biomedical Star" among Ningbo's most investment-worthy enterprises
ISO13485 certification obtained
Strategic partnership with Zhejiang Orient Gene Biotech
Recognized as National High-Tech Enterprise
Recognized as Ningbo 'Specialized & Innovative' SME
Frequently Asked Questions
Who is Ningbo Inarray Biomedical Systems Co., Ltd?
Ningbo Inarray Biomedical Systems Co., Ltd (Yinrui Bio) is a high-precision instrument manufacturer founded in June 2018 in Cixi, Zhejiang, China. The company specializes in portable molecular diagnostics, producing the CarryOn Portable PCR Analyzer and microfluidic test chips. The core technical team comprises experts from the Chinese Academy of Sciences, led by founder Dr. Yu Jun, co-founder of BGI (Beijing Genomics Institute).
What certifications does Yinrui Bio hold?
Yinrui Bio does not hold CE certification for the CarryOn PCR device or test reagent kits. The manufacturing facility maintains ISO 13485 quality management system certification. The company is also recognized as a National High-Tech Enterprise and a Ningbo 'Specialized & Innovative' SME, with a comprehensive IP portfolio of 25 invention patents, 12 design patents, and 6 software copyrights.
Does Yinrui Bio offer distribution partnerships?
Yes, Yinrui Bio is actively seeking distribution partners worldwide. The company provides support for distributors including marketing materials, technical training, and competitive pricing structures. Interested distributors can contact the company through the website inquiry form or WhatsApp to discuss partnership opportunities in their region.
Where is Yinrui Bio's manufacturing facility located?
Yinrui Bio's R&D and manufacturing facility is located at the Cixi Industrial Application Technology Research Institute in Cixi, Zhejiang Province, China. The facility features nearly 3,000 square meters of laboratory space, GMP-certified workshops, and comprehensive production equipment for manufacturing the CarryOn device and microfluidic test chips.
Explore More
Ready to Bring PCR Testing to Your Clinic?
Join veterinary clinics in 30+ countries using CarryOn for rapid, accurate diagnostics.